Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
Moujalled, DM; Hanna, DT; Hediyeh-zadeh, S; Pomilio, G; Brown, L; Litalien, V; Bartolo, R; Fleming, S; Chanrion, M; Banquet, S; Maragno, AL; Kraus-Berthier, L; Schoumacher, M; Mullighan, CG; Georgiou, A; White, CA; Lessene, G; Huang, DCS; Roberts, AW; Geneste, O; Rasmussen, L; Davis, MJ; Ekert, PG; Wei, A; Ng, AP; Khaw, SL
Moujalled, DM (corresponding author), Monash Univ, Australian Ctr Blood Dis, Level 1 Walkway Via Alfred Ctr,99 Commercial Rd, Melbourne, Vic 3004, Australia.; Hanna, DT (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.; Hanna, DT (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.; Hanna, DT (corresponding author), Royal Childrens Hosp, Melbourne, Vic, Australia.
BLOOD ADVANCES, 2020; 4 (12): 2762
